Neovasc Inc (NVCN.CA) Stock Price & Overview
TSX:NVCN • CA64065J4037
Current stock price
The current stock price of NVCN.CA is 40.15 CAD. Today NVCN.CA is up by 0.58%. In the past month the price decreased by -1.21%. In the past year, price increased by 203.02%.
NVCN.CA Key Statistics
- Market Cap
- 110.566M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -142.14
- Dividend Yield
- N/A
NVCN.CA Stock Performance
NVCN.CA Stock Chart
NVCN.CA Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to NVCN.CA. When comparing the yearly performance of all stocks, NVCN.CA is one of the better performing stocks in the market, outperforming 98.96% of all stocks.
NVCN.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to NVCN.CA. NVCN.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
NVCN.CA Earnings
NVCN.CA Forecast & Estimates
NVCN.CA Groups
Sector & Classification
NVCN.CA Financial Highlights
Over the last trailing twelve months NVCN.CA reported a non-GAAP Earnings per Share(EPS) of -142.14. The EPS decreased by -1143.35% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0.81 |
NVCN.CA Ownership
NVCN.CA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| PRN | PROFOUND MEDICAL CORP | N/A | 336.872M | ||
| TLT | THERALASE TECHNOLOGIES INC | N/A | 100.253M | ||
| MIR | MEDMIRA INC | N/A | 45.499M | ||
| PINK | PERIMETER MEDICAL IMAGING AI | N/A | 42.614M | ||
| CNVI | CONAVI MEDICAL CORP | N/A | 41.396M | ||
| ASG | AURORA SPINE CORP | N/A | 21.236M | ||
| NSCI | NANALYSIS SCIENTIFIC CORP | N/A | 20.075M | ||
| VPT | VENTRIPOINT DIAGNOSTICS LTD | N/A | 18.766M | ||
| MDX | MEDX HEALTH CORP | N/A | 18.036M | ||
| THRM | THERMA BRIGHT INC | N/A | 3.409M | ||
| VER-H | VERISANTE TECHNOLOGY INC | N/A | 659.1K | ||
| VVTM | VVT MED INC | N/A |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Toronto Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
About NVCN.CA
Company Profile
Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. The company is headquartered in Richmond British Columbia, British Columbia. The company went IPO on 2001-05-23. The firm develops, manufactures, and markets products for the cardiovascular marketplace. The firm is engaged in the development of minimally invasive therapies in cardiovascular care: refractory angina and mitral valve regurgitation. Its products include the Neovasc Reducer (Reducer), for the treatment of refractory angina, and the Tiara (Tiara), for the transcatheter treatment of mitral valve disease, which is currently under clinical investigation in the United States, Canada, Israel and Europe. The firm operates through one business segment: the development, manufacturing and marketing of medical devices. The firm's subsidiaries include Neovasc Medical Inc., Neovasc Tiara Inc., Neovasc (US) Inc., Neovasc Medical Ltd., B-Balloon Ltd., Neovasc GmbH, and Neovasc Management Inc. The firm carries its business in Canada, the United States and Europe.
Company Info
IPO: 2001-05-23
Neovasc Inc
Richmond, 5138-13562 Maycrest Way
Richmond British Columbia BRITISH COLUMBIA V6V 2J7 CA
CEO: Fredericus A. Colen
Employees: 71
Phone: 16042704344.0
Neovasc Inc / NVCN.CA FAQ
What does NVCN do?
Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. The company is headquartered in Richmond British Columbia, British Columbia. The company went IPO on 2001-05-23. The firm develops, manufactures, and markets products for the cardiovascular marketplace. The firm is engaged in the development of minimally invasive therapies in cardiovascular care: refractory angina and mitral valve regurgitation. Its products include the Neovasc Reducer (Reducer), for the treatment of refractory angina, and the Tiara (Tiara), for the transcatheter treatment of mitral valve disease, which is currently under clinical investigation in the United States, Canada, Israel and Europe. The firm operates through one business segment: the development, manufacturing and marketing of medical devices. The firm's subsidiaries include Neovasc Medical Inc., Neovasc Tiara Inc., Neovasc (US) Inc., Neovasc Medical Ltd., B-Balloon Ltd., Neovasc GmbH, and Neovasc Management Inc. The firm carries its business in Canada, the United States and Europe.
Can you provide the latest stock price for Neovasc Inc?
The current stock price of NVCN.CA is 40.15 CAD. The price increased by 0.58% in the last trading session.
What is the dividend status of Neovasc Inc?
NVCN.CA does not pay a dividend.
What is the ChartMill technical and fundamental rating of NVCN stock?
NVCN.CA has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Where is Neovasc Inc (NVCN.CA) stock traded?
NVCN.CA stock is listed on the Toronto Stock Exchange exchange.
Would investing in Neovasc Inc be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on NVCN.CA.